Literature DB >> 17257357

An evaluation of blood volume changes during ultrafiltration pulses and natriuretic peptides in the assessment of dry weight in hemodialysis patients.

Anouk C M van de Pol1, Leon A Frenken, Karin Moret, Ruben Baumgarten, Frank M van der Sande, Charles M Beerenhout, Jeroen P Kooman, Karel M Leunissen.   

Abstract

Changes in blood volume (BV) during dialysis as well as plasma levels of brain natriuretic peptide (BNP) and N-terminal (NT) pro-BNP levels are possible tools to assess dry weight in hemodialysis (HD) patients. The aim of the study was to compare these parameters with other non-invasive techniques used to assess dry weight in HD patients, and to study their relation with intradialytic hypotension (IDH) and the presence of cardiovascular disease BV changes during HD, both during regular dialysis and during an ultrafiltration pulse, plasma levels of NT pro-BNP and BNP, and vena cava diameter index (VCDI) were assessed in a cohort of 66 HD patients, which was subdivided according to tertiles of total body water (TBW) corrected for body weight, assessed by bioimpedance analysis. Parameters were also related to the presence of IDH and history of cardiovascular disease. The decline in BV during regular dialysis and during an ultrafiltration pulse, as well as VCDI and BNP were significantly different between the tertiles of normalized TBW, but refill after the ultrafiltration pulse and NT pro-BNP were not. Only VCDI and the decline in BV during regular dialysis were significantly different between patients with or without IDH. Vena cava diameter index, BNP, and NT pro-BNP were significantly higher in patients with cardiovascular disease. Using bioimpedance as the reference method, changes in BV, either during regular dialysis or during an ultrafiltration pulse, as well as VCDI and BNP are all indicative of hydration state in dialysis patients, but refill after an ultrafiltration pulse is not. Only VCDI and BV changes were related to IDH. The presence of cardiovascular disease appears to influence both VCDI as well as BNP.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17257357     DOI: 10.1111/j.1542-4758.2007.00154.x

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  10 in total

1.  Brain Natriuretic Peptide Is a Marker of Fluid Overload in Incident Hemodialysis Patients.

Authors:  Charles Chazot; Margaux Rozes; Cyril Vo-Van; Patrik Deleaval; Jean-Marc Hurot; Christie Lorriaux; Brice Mayor; Eric Zaoui; Guillaume Jean
Journal:  Cardiorenal Med       Date:  2017-04-29       Impact factor: 2.041

2.  Associations between bioelectrical impedance parameters and cardiovascular events in chronic dialysis patients.

Authors:  Aline de Araujo Antunes; Francieli Delatim Vannini; Liciana Vaz de Arruda Silveira; Pasqual Barretti; Luis Cuadrado Martin; Jacqueline Costa Teixeira Caramori
Journal:  Int Urol Nephrol       Date:  2012-12-04       Impact factor: 2.370

3.  Plasma Brain Natriuretic Peptide Levels in Cardiac Function Assessment in Chronic Dialysis Patients.

Authors:  R Sanjuan; S Martín Oliva; M L Blasco; M Puchades; I Torregrosa; R García Ramón; A Miguel Carrasco
Journal:  Cardiorenal Med       Date:  2011-07-01       Impact factor: 2.041

4.  Inferior vena cava collapsibility to guide fluid removal in slow continuous ultrafiltration: a pilot study.

Authors:  Giovanna Guiotto; Mario Masarone; Fiorella Paladino; Enrico Ruggiero; Sean Scott; Sossio Verde; Fernando Schiraldi
Journal:  Intensive Care Med       Date:  2010-01-22       Impact factor: 17.440

5.  The role of natriuretic peptides in volume assessment and mortality prediction in Haemodialysis patients.

Authors:  Murugan Sivalingam; Enric Vilar; Suresh Mathavakkannan; Ken Farrington
Journal:  BMC Nephrol       Date:  2015-12-29       Impact factor: 2.388

6.  Investigation of optimum N-terminal probrain natriuretic peptide level in patients on maintained hemodialysis.

Authors:  Lan Chen; Ying-Ying Chen; Yi-Sheng Ling; Chun-Hua Lin; Jin-Xuan He; Tian-Jun Guan
Journal:  Ren Fail       Date:  2017-11       Impact factor: 2.606

7.  Change in N-terminal-pro-B-type-natriuretic-peptide and the risk of sudden death, stroke, myocardial infarction, and all-cause mortality in diabetic dialysis patients.

Authors:  Karl Winkler; Christoph Wanner; Christiane Drechsler; Jürgen Lilienthal; Winfried März; Vera Krane
Journal:  Eur Heart J       Date:  2008-07-09       Impact factor: 29.983

Review 8.  Vasopressin and prevention of hypotension during hemodialysis.

Authors:  Seyed Seifollah Beladi Mousavi; Mohamad Reza Tamadon
Journal:  Iran Red Crescent Med J       Date:  2014-11-05       Impact factor: 0.611

9.  Clinical Value of Natriuretic Peptides in Predicting Time to Dialysis in Stage 4 and 5 Chronic Kidney Disease Patients.

Authors:  Sofia Sundqvist; Thomas Larson; Bruno Cauliez; Fabrice Bauer; Audrey Dumont; Frank Le Roy; Mélanie Hanoy; Caroline Fréguin-Bouilland; Michel Godin; Dominique Guerrot
Journal:  PLoS One       Date:  2016-08-22       Impact factor: 3.240

Review 10.  Acute Kidney Injury in Heart Failure Revisited-The Ameliorating Impact of "Decongestive Diuresis" on Renal Dysfunction in Type 1 Acute Cardiorenal Syndrome: Accelerated Rising Pro B Naturetic Peptide Is a Predictor of Good Renal Prognosis.

Authors:  Macaulay Amechi Chukwukadibia Onuigbo; Nneoma Agbasi; Mohan Sengodan; Karen Flores Rosario
Journal:  J Clin Med       Date:  2017-08-29       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.